Global Glioblastoma Multiforme Treatment Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Glioblastoma Multiforme Treatment Revenue
1.4 Market by Type
1.4.1 Global Glioblastoma Multiforme Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Bevacizumab (Avastin)
1.4.3 Carmustine (BiCNU)
1.4.4 Temozolomide (Temodar and Temodal and Temcad)
1.5 Market by Application
1.5.1 Global Glioblastoma Multiforme Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Glioblastoma Multiforme Treatment Market Perspective (2015-2026)
2.2 Global Glioblastoma Multiforme Treatment Growth Trends by Regions
2.2.1 Glioblastoma Multiforme Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Glioblastoma Multiforme Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Glioblastoma Multiforme Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Glioblastoma Multiforme Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Glioblastoma Multiforme Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Glioblastoma Multiforme Treatment Players by Market Size
3.1.1 Global Top Glioblastoma Multiforme Treatment Players by Revenue (2015-2020)
3.1.2 Global Glioblastoma Multiforme Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Glioblastoma Multiforme Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Glioblastoma Multiforme Treatment Market Concentration Ratio
3.2.1 Global Glioblastoma Multiforme Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Glioblastoma Multiforme Treatment Revenue in 2019
3.3 Glioblastoma Multiforme Treatment Key Players Head office and Area Served
3.4 Key Players Glioblastoma Multiforme Treatment Product Solution and Service
3.5 Date of Enter into Glioblastoma Multiforme Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Glioblastoma Multiforme Treatment Historic Market Size by Type (2015-2020)
4.2 Global Glioblastoma Multiforme Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Glioblastoma Multiforme Treatment Market Size by Application (2015-2020)
5.2 Global Glioblastoma Multiforme Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Glioblastoma Multiforme Treatment Market Size (2015-2020)
6.2 Glioblastoma Multiforme Treatment Key Players in North America (2019-2020)
6.3 North America Glioblastoma Multiforme Treatment Market Size by Type (2015-2020)
6.4 North America Glioblastoma Multiforme Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Glioblastoma Multiforme Treatment Market Size (2015-2020)
7.2 Glioblastoma Multiforme Treatment Key Players in Europe (2019-2020)
7.3 Europe Glioblastoma Multiforme Treatment Market Size by Type (2015-2020)
7.4 Europe Glioblastoma Multiforme Treatment Market Size by Application (2015-2020)
8 China
8.1 China Glioblastoma Multiforme Treatment Market Size (2015-2020)
8.2 Glioblastoma Multiforme Treatment Key Players in China (2019-2020)
8.3 China Glioblastoma Multiforme Treatment Market Size by Type (2015-2020)
8.4 China Glioblastoma Multiforme Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Glioblastoma Multiforme Treatment Market Size (2015-2020)
9.2 Glioblastoma Multiforme Treatment Key Players in Japan (2019-2020)
9.3 Japan Glioblastoma Multiforme Treatment Market Size by Type (2015-2020)
9.4 Japan Glioblastoma Multiforme Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Glioblastoma Multiforme Treatment Market Size (2015-2020)
10.2 Glioblastoma Multiforme Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Glioblastoma Multiforme Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Glioblastoma Multiforme Treatment Market Size by Application (2015-2020)
11 India
11.1 India Glioblastoma Multiforme Treatment Market Size (2015-2020)
11.2 Glioblastoma Multiforme Treatment Key Players in India (2019-2020)
11.3 India Glioblastoma Multiforme Treatment Market Size by Type (2015-2020)
11.4 India Glioblastoma Multiforme Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Glioblastoma Multiforme Treatment Market Size (2015-2020)
12.2 Glioblastoma Multiforme Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Glioblastoma Multiforme Treatment Market Size by Type (2015-2020)
12.4 Central & South America Glioblastoma Multiforme Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 AbbVie, Inc
13.1.1 AbbVie, Inc Company Details
13.1.2 AbbVie, Inc Business Overview
13.1.3 AbbVie, Inc Glioblastoma Multiforme Treatment Introduction
13.1.4 AbbVie, Inc Revenue in Glioblastoma Multiforme Treatment Business (2015-2020))
13.1.5 AbbVie, Inc Recent Development
13.2 Activartis GmbH
13.2.1 Activartis GmbH Company Details
13.2.2 Activartis GmbH Business Overview
13.2.3 Activartis GmbH Glioblastoma Multiforme Treatment Introduction
13.2.4 Activartis GmbH Revenue in Glioblastoma Multiforme Treatment Business (2015-2020)
13.2.5 Activartis GmbH Recent Development
13.3 Agenus Inc
13.3.1 Agenus Inc Company Details
13.3.2 Agenus Inc Business Overview
13.3.3 Agenus Inc Glioblastoma Multiforme Treatment Introduction
13.3.4 Agenus Inc Revenue in Glioblastoma Multiforme Treatment Business (2015-2020)
13.3.5 Agenus Inc Recent Development
13.4 Arog Pharmaceuticals, Inc
13.4.1 Arog Pharmaceuticals, Inc Company Details
13.4.2 Arog Pharmaceuticals, Inc Business Overview
13.4.3 Arog Pharmaceuticals, Inc Glioblastoma Multiforme Treatment Introduction
13.4.4 Arog Pharmaceuticals, Inc Revenue in Glioblastoma Multiforme Treatment Business (2015-2020)
13.4.5 Arog Pharmaceuticals, Inc Recent Development
13.5 Bristol-Myers Squibb Company
13.5.1 Bristol-Myers Squibb Company Company Details
13.5.2 Bristol-Myers Squibb Company Business Overview
13.5.3 Bristol-Myers Squibb Company Glioblastoma Multiforme Treatment Introduction
13.5.4 Bristol-Myers Squibb Company Revenue in Glioblastoma Multiforme Treatment Business (2015-2020)
13.5.5 Bristol-Myers Squibb Company Recent Development
13.6 Cavion LLC
13.6.1 Cavion LLC Company Details
13.6.2 Cavion LLC Business Overview
13.6.3 Cavion LLC Glioblastoma Multiforme Treatment Introduction
13.6.4 Cavion LLC Revenue in Glioblastoma Multiforme Treatment Business (2015-2020)
13.6.5 Cavion LLC Recent Development
13.7 Celldex Therapeutics Inc
13.7.1 Celldex Therapeutics Inc Company Details
13.7.2 Celldex Therapeutics Inc Business Overview
13.7.3 Celldex Therapeutics Inc Glioblastoma Multiforme Treatment Introduction
13.7.4 Celldex Therapeutics Inc Revenue in Glioblastoma Multiforme Treatment Business (2015-2020)
13.7.5 Celldex Therapeutics Inc Recent Development
13.8 Cortice Biosciences
13.8.1 Cortice Biosciences Company Details
13.8.2 Cortice Biosciences Business Overview
13.8.3 Cortice Biosciences Glioblastoma Multiforme Treatment Introduction
13.8.4 Cortice Biosciences Revenue in Glioblastoma Multiforme Treatment Business (2015-2020)
13.8.5 Cortice Biosciences Recent Development
13.9 Exelixis Inc
13.9.1 Exelixis Inc Company Details
13.9.2 Exelixis Inc Business Overview
13.9.3 Exelixis Inc Glioblastoma Multiforme Treatment Introduction
13.9.4 Exelixis Inc Revenue in Glioblastoma Multiforme Treatment Business (2015-2020)
13.9.5 Exelixis Inc Recent Development
13.10 F. Hoffmann-La Roche Ltd.
13.10.1 F. Hoffmann-La Roche Ltd. Company Details
13.10.2 F. Hoffmann-La Roche Ltd. Business Overview
13.10.3 F. Hoffmann-La Roche Ltd. Glioblastoma Multiforme Treatment Introduction
13.10.4 F. Hoffmann-La Roche Ltd. Revenue in Glioblastoma Multiforme Treatment Business (2015-2020)
13.10.5 F. Hoffmann-La Roche Ltd. Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of TablesTable 1. Glioblastoma Multiforme Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Glioblastoma Multiforme Treatment Revenue
Table 3. Ranking of Global Top Glioblastoma Multiforme Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Glioblastoma Multiforme Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Bevacizumab (Avastin)
Table 6. Key Players of Carmustine (BiCNU)
Table 7. Key Players of Temozolomide (Temodar and Temodal and Temcad)
Table 8. Global Glioblastoma Multiforme Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Glioblastoma Multiforme Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Glioblastoma Multiforme Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Glioblastoma Multiforme Treatment Market Share by Regions (2015-2020)
Table 12. Global Glioblastoma Multiforme Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Glioblastoma Multiforme Treatment Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Glioblastoma Multiforme Treatment Market Growth Strategy
Table 18. Main Points Interviewed from Key Glioblastoma Multiforme Treatment Players
Table 19. Global Glioblastoma Multiforme Treatment Revenue by Players (2015-2020) (Million US$)
Table 20. Global Glioblastoma Multiforme Treatment Market Share by Players (2015-2020)
Table 21. Global Top Glioblastoma Multiforme Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glioblastoma Multiforme Treatment as of 2019)
Table 22. Global Glioblastoma Multiforme Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Glioblastoma Multiforme Treatment Product Solution and Service
Table 25. Date of Enter into Glioblastoma Multiforme Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Glioblastoma Multiforme Treatment Market Size by Type (2015-2020) (Million US$)
Table 28. Global Glioblastoma Multiforme Treatment Market Size Share by Type (2015-2020)
Table 29. Global Glioblastoma Multiforme Treatment Revenue Market Share by Type (2021-2026)
Table 30. Global Glioblastoma Multiforme Treatment Market Size Share by Application (2015-2020)
Table 31. Global Glioblastoma Multiforme Treatment Market Size by Application (2015-2020) (Million US$)
Table 32. Global Glioblastoma Multiforme Treatment Market Size Share by Application (2021-2026)
Table 33. North America Key Players Glioblastoma Multiforme Treatment Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Glioblastoma Multiforme Treatment Market Share (2019-2020)
Table 35. North America Glioblastoma Multiforme Treatment Market Size by Type (2015-2020) (Million US$)
Table 36. North America Glioblastoma Multiforme Treatment Market Share by Type (2015-2020)
Table 37. North America Glioblastoma Multiforme Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. North America Glioblastoma Multiforme Treatment Market Share by Application (2015-2020)
Table 39. Europe Key Players Glioblastoma Multiforme Treatment Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Glioblastoma Multiforme Treatment Market Share (2019-2020)
Table 41. Europe Glioblastoma Multiforme Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Glioblastoma Multiforme Treatment Market Share by Type (2015-2020)
Table 43. Europe Glioblastoma Multiforme Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Glioblastoma Multiforme Treatment Market Share by Application (2015-2020)
Table 45. China Key Players Glioblastoma Multiforme Treatment Revenue (2019-2020) (Million US$)
Table 46. China Key Players Glioblastoma Multiforme Treatment Market Share (2019-2020)
Table 47. China Glioblastoma Multiforme Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. China Glioblastoma Multiforme Treatment Market Share by Type (2015-2020)
Table 49. China Glioblastoma Multiforme Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. China Glioblastoma Multiforme Treatment Market Share by Application (2015-2020)
Table 51. Japan Key Players Glioblastoma Multiforme Treatment Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Glioblastoma Multiforme Treatment Market Share (2019-2020)
Table 53. Japan Glioblastoma Multiforme Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Glioblastoma Multiforme Treatment Market Share by Type (2015-2020)
Table 55. Japan Glioblastoma Multiforme Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Glioblastoma Multiforme Treatment Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Glioblastoma Multiforme Treatment Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Glioblastoma Multiforme Treatment Market Share (2019-2020)
Table 59. Southeast Asia Glioblastoma Multiforme Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Glioblastoma Multiforme Treatment Market Share by Type (2015-2020)
Table 61. Southeast Asia Glioblastoma Multiforme Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Glioblastoma Multiforme Treatment Market Share by Application (2015-2020)
Table 63. India Key Players Glioblastoma Multiforme Treatment Revenue (2019-2020) (Million US$)
Table 64. India Key Players Glioblastoma Multiforme Treatment Market Share (2019-2020)
Table 65. India Glioblastoma Multiforme Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. India Glioblastoma Multiforme Treatment Market Share by Type (2015-2020)
Table 67. India Glioblastoma Multiforme Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. India Glioblastoma Multiforme Treatment Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Glioblastoma Multiforme Treatment Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Glioblastoma Multiforme Treatment Market Share (2019-2020)
Table 71. Central & South America Glioblastoma Multiforme Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Glioblastoma Multiforme Treatment Market Share by Type (2015-2020)
Table 73. Central & South America Glioblastoma Multiforme Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Glioblastoma Multiforme Treatment Market Share by Application (2015-2020)
Table 75. AbbVie, Inc Company Details
Table 76. AbbVie, Inc Business Overview
Table 77. AbbVie, Inc Product
Table 78. AbbVie, Inc Revenue in Glioblastoma Multiforme Treatment Business (2015-2020) (Million US$)
Table 79. AbbVie, Inc Recent Development
Table 80. Activartis GmbH Company Details
Table 81. Activartis GmbH Business Overview
Table 82. Activartis GmbH Product
Table 83. Activartis GmbH Revenue in Glioblastoma Multiforme Treatment Business (2015-2020) (Million US$)
Table 84. Activartis GmbH Recent Development
Table 85. Agenus Inc Company Details
Table 86. Agenus Inc Business Overview
Table 87. Agenus Inc Product
Table 88. Agenus Inc Revenue in Glioblastoma Multiforme Treatment Business (2015-2020) (Million US$)
Table 89. Agenus Inc Recent Development
Table 90. Arog Pharmaceuticals, Inc Company Details
Table 91. Arog Pharmaceuticals, Inc Business Overview
Table 92. Arog Pharmaceuticals, Inc Product
Table 93. Arog Pharmaceuticals, Inc Revenue in Glioblastoma Multiforme Treatment Business (2015-2020) (Million US$)
Table 94. Arog Pharmaceuticals, Inc Recent Development
Table 95. Bristol-Myers Squibb Company Company Details
Table 96. Bristol-Myers Squibb Company Business Overview
Table 97. Bristol-Myers Squibb Company Product
Table 98. Bristol-Myers Squibb Company Revenue in Glioblastoma Multiforme Treatment Business (2015-2020) (Million US$)
Table 99. Bristol-Myers Squibb Company Recent Development
Table 100. Cavion LLC Company Details
Table 101. Cavion LLC Business Overview
Table 102. Cavion LLC Product
Table 103. Cavion LLC Revenue in Glioblastoma Multiforme Treatment Business (2015-2020) (Million US$)
Table 104. Cavion LLC Recent Development
Table 105. Celldex Therapeutics Inc Company Details
Table 106. Celldex Therapeutics Inc Business Overview
Table 107. Celldex Therapeutics Inc Product
Table 108. Celldex Therapeutics Inc Revenue in Glioblastoma Multiforme Treatment Business (2015-2020) (Million US$)
Table 109. Celldex Therapeutics Inc Recent Development
Table 110. Cortice Biosciences Business Overview
Table 111. Cortice Biosciences Product
Table 112. Cortice Biosciences Company Details
Table 113. Cortice Biosciences Revenue in Glioblastoma Multiforme Treatment Business (2015-2020) (Million US$)
Table 114. Cortice Biosciences Recent Development
Table 115. Exelixis Inc Company Details
Table 116. Exelixis Inc Business Overview
Table 117. Exelixis Inc Product
Table 118. Exelixis Inc Revenue in Glioblastoma Multiforme Treatment Business (2015-2020) (Million US$)
Table 119. Exelixis Inc Recent Development
Table 120. F. Hoffmann-La Roche Ltd. Company Details
Table 121. F. Hoffmann-La Roche Ltd. Business Overview
Table 122. F. Hoffmann-La Roche Ltd. Product
Table 123. F. Hoffmann-La Roche Ltd. Revenue in Glioblastoma Multiforme Treatment Business (2015-2020) (Million US$)
Table 124. F. Hoffmann-La Roche Ltd. Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Glioblastoma Multiforme Treatment Market Share by Type: 2020 VS 2026
Figure 2. Bevacizumab (Avastin) Features
Figure 3. Carmustine (BiCNU) Features
Figure 4. Temozolomide (Temodar and Temodal and Temcad) Features
Figure 5. Global Glioblastoma Multiforme Treatment Market Share by Application: 2020 VS 2026
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Others Case Studies
Figure 9. Glioblastoma Multiforme Treatment Report Years Considered
Figure 10. Global Glioblastoma Multiforme Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Glioblastoma Multiforme Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Glioblastoma Multiforme Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Glioblastoma Multiforme Treatment Market Share by Players in 2019
Figure 15. Global Top Glioblastoma Multiforme Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glioblastoma Multiforme Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Glioblastoma Multiforme Treatment Revenue in 2019
Figure 17. North America Glioblastoma Multiforme Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Glioblastoma Multiforme Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Glioblastoma Multiforme Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Glioblastoma Multiforme Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Glioblastoma Multiforme Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Glioblastoma Multiforme Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Glioblastoma Multiforme Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed